Navigation Links
Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
Date:6/9/2009

SPRINGFIELD, Va., June 9 /PRNewswire/ -- Methuselah Foundation has identified Organovo, Inc. as a leader in the extraordinary science of bio-printing. The US Department of Health and Human Services predicts: "Within 20 years regenerative medicine will be the standard of care for replacing all tissue/organ systems in the body." Organovo, with the support of Methuselah Foundation, is applying its breakthrough organ printing technologies to make that prediction a reality.

"Methuselah Foundation, through the generosity of its donors, funds multiple strategies designed to extend healthy human life," according to Dave Gobel, Founder and CEO.

The MLife Sciences program of Methuselah Foundation seeks long-term strategies to combat the progressive, degenerative process of biological aging. What is accepted as "aging" is a wide range of damage that occurs at the cellular level. Our bodies show and feel the results: functionality is lost and age-related frailty, disability and disease take over.

Organovo is developing a very promising solution. Their 3-dimensional bio-printer lays down bio-ink that fuses into complex tissue, creating new tissue to replace diseased tissue. Rejection of transplanted tissue is not a concern; the cells that are used can be taken from youthful progenitor cells from the patient to replace the older diseased cells.

Keith Murphy, CEO of Organovo, looks ahead, "Organovo has an exciting technology platform that has attracted broad investment at a time when capital is not free flowing. The technology has immediate applications in cardiovascular therapeutics, and as the platform of choice for three dimensional tissue development. In the future Organovo hopes to provide 'Tissue on Demand' for surgical applications."

Organovo, Inc. is a seed-stage regenerative medicine company that applies proprietary organ printing technology to solve critical problems in transplant medicine, cardiovascular medicine, tissue repair, and medical research. Organovo aims to solve complex medical problems with one overarching goal: to benefit the health and lives of patients. www.organovo.com

Methuselah Foundation is a non-profit medical charity dedicated to extending healthy human life. The Foundation supports strategies that accelerate progress toward a comprehensive cure for age-related disease, disability, and suffering. Supported by the donations of individuals and organizations, the Foundation replaces resignation with an understanding of what is possible. Methuselah Foundation's programs include near, mid-and long-term strategies that advance the mission of ending age-related disease through awareness, education, scientific research and direct community outreach. www.methuselahfoundation.org

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com


'/>"/>
SOURCE Methuselah Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Protein-printing technique gives snapshots of immune system defense
2. Americas on the Waterway Supports US Oncology Foundation
3. Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research
4. The Foundation for Biomedical Research Wins Telly Award for Majestic
5. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
6. Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22
7. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
8. Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools
9. The Crohns & Colitis Foundation of America and Shire Launch Virtual IBD March on the Hill to Increase Funding for Digestive Disease Research
10. Bayer CropScience Donates $1.1 Million to United Fresh Research & Education Foundation to Create the Center for Global Produce Sustainability
11. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Services portfolio to include an array of biochemical analyses critical for Lead ... to drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism ...
(Date:2/23/2017)... 23, 2017  Imanis Life Sciences announced today ... oncolytic vaccinia viruses for virotherapy research. These viruses ... Genelux,s proprietary, vaccinia virus-based technology platform for research ... into a partnership with Genelux to offer researchers, ... for use in research," said Dr. Kah ...
(Date:2/23/2017)... Winston-Salem, NC (PRWEB) , ... February 23, 2017 , ... ... pleased to announce a new partnership with Compass Research . GGI's mission is ... gifting a vaccine to a child in need in honor of each clinical trial ...
Breaking Biology Technology:
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):